Fremont, California.,, March 20, 2025 / Prnewswire / – Benign lifeA pioneering biotechnology company dedicated to the progression of mental and neurological health, announces an international donation campaign during the week of the celebration of neurodiversity. As part of its commitment to promote innovative solutions for neurological well-being, Benued Life’s The parent company also expands its efforts in clinical and pioneering research in the development of new generation probiotic strains targeting the neurodivers conditions.
Expansion of clinical research to support the communities of Neurodivers
Benign life Expands its clinical research portfolio in order to deepen the understanding and therapeutic applications of probiotics under conditions related to neurodiversity. A next clinical study will explore the impact of a psychobiotic for autistic adults. Bénéd Biomedical, the parent company of Benign lifelaunches a new clinical trial by focusing on the qualitative experience of autistic adults with a key collaborator in Taiwan. This pioneering research will be the first of its kind to assess the impact of a psychobiotic in autistic adults rather than children. Benign life also consults the DR Jack GilbertProfessor at the UCSD and director of the microbiome and Metagénomics Center, concerning the advancement of this preliminary research in adults autistic.
The study is based on Benued Life’s The work existing in microbiome -based neurological health solutions, taking advantage of rigorous scientific methodologies to improve results for neurodivergent individuals. This initiative is aligned with the broader efforts of Biomedical Bened in psychobiotics, which have demonstrated promising potential in conditions such as Autism and Parkinson’s disease.
Advance psychobiotic research and the development of tension
In addition to clinical trials, Benign life Expans its research programs to identify how their neuroactive probiotic strains can further support cognitive function, emotional regulation and overall brain health. Pulling the expertise of the pioneering work of Bened Biomedical in the intestinal axis (GBA), Benign life Refine and develop more efficient and targeted probiotics that offer tangible advantages to the populations of Neurodivers.
The company continues to explore the impact of L. Plants PS128A key psychobiotic strain initially discovered by the Biomedical Bened, and its applications in the fight against neurological conditions such as autism and neurodegenerative diseases.
A commitment to inclusive innovation
“In Bened Life, we recognize that neurodiversity is an essential element of human diversity. Our investments extended in research and innovation aim to guarantee that individuals with neurological differences have access to scientifically sustained effective solutions,” said Frankie ChengCEO of Benign life.
“By integrating advanced probiotic science with a commitment to inclusiveness, we hope to contribute significantly to the well-being of neurodivergent individuals and their families.”
Benign life To launch the donation campaign during the week of the celebration of neurodiversity
As part of its current efforts to support and empower neurodivergent individuals, Benign life will organize an awareness and advocacy event focused on the community throughout the week of the celebration of neurodiversity 2025. March 17,, Benign life Encourages individuals, parents and neurodivergent caregivers Share their stories Navigate in a neurotypical world.
Benign life will associate with Insseed, a company of Taiwanese probiotics to make a donation 1 USD 1 For each story shared with the Taiwan Neurodiversity Support Association in order to amplify the votes of neurodiverses, to promote understanding and to encourage significant conversations on inclusion and support on the global scale.
By combining the science of pioneering microbiomas with a mission -based approach, Benign life continues to maintain its vision to transform the landscape of support for neurodiversity. The company invites researchers, health and community professionals in general to join its efforts to create a more inclusive future for all.
Benign life Specialized in the probiotic and postbiotic products that influence the brain via the signaling of the intestinal brain microbiome. Their flagship product NeuronelⓇ DeputyThe first medical brain medical probiotics presents the clinically studied owner strain PS128 and provides food support to specific neurological conditions. Thanks to rigorous clinical research and inclusive commercial practices, Benign life Aims to help make a world where neurodivergen and disabled people can thrive.
For more information, visit the Benign life website.
Contact:
William Chen
wlchen89@benedbiomed.com
Show original content to download the multimedia:https://www.prnewswire.com/apac/news-releases/bened-life-leads-dvocacy-campaign-alongside-research-innovation-dering-neurodiversity-celebration-week-302406782.html
Source Bened Life Inc.
